Jinsong Liu Selected Research

Jinsong Liu Research Topics

Disease

171	Neoplasms (Cancer) 07/2022 - 08/2002
81	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 03/2003
40	Carcinoma (Carcinomatosis) 03/2022 - 09/2003
27	Carcinogenesis 06/2015 - 03/2003
14	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2006
11	Ovarian Epithelial Carcinoma 03/2017 - 02/2004
10	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2003
8	Infections 01/2022 - 08/2003
8	Endometrioid Carcinoma 06/2011 - 10/2003
5	Osteoporosis 04/2022 - 12/2014
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2006
5	Polyploidy 01/2022 - 06/2013
5	Insulin Resistance 01/2020 - 04/2008
5	Lung Neoplasms (Lung Cancer) 01/2017 - 06/2009
5	Ascites 03/2012 - 03/2004
4	Endometrial Neoplasms (Endometrial Cancer) 12/2021 - 07/2006
4	Cystadenoma 01/2014 - 10/2004
4	Microsatellite Instability 11/2006 - 10/2003
3	Bone Resorption 11/2021 - 12/2014
3	Adenocarcinoma 02/2016 - 10/2006
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2015 - 01/2008
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2014 - 09/2003
3	Genomic Instability 07/2013 - 06/2010
3	Hypoxia (Hypoxemia) 06/2013 - 02/2007
3	Colorectal Neoplasms (Colorectal Cancer) 09/2009 - 10/2003
3	Type 2 Diabetes Mellitus (MODY) 03/2009 - 04/2008
3	Motion Sickness (Airsickness) 02/2006 - 05/2004
3	Granulosa Cell Tumor 10/2005 - 06/2003
2	Diarrhea 06/2022 - 02/2009
2	Dyspepsia (Indigestion) 06/2022 - 01/2021
2	AIDS-Related Complex (ARC) 04/2022 - 01/2014
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 03/2017
2	Weight Loss (Weight Reduction) 01/2022 - 08/2019

Drug/Important Bio-Agent (IBA)

49	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2003
18	Small Interfering RNA (siRNA)IBA 01/2018 - 08/2003
16	Messenger RNA (mRNA)IBA 09/2021 - 02/2004
12	Pharmaceutical PreparationsIBA 01/2022 - 04/2011
11	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 04/2003
9	Biological ProductsIBA 01/2022 - 03/2004
9	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2005
8	CytokinesIBA 01/2021 - 03/2004
7	Estrogens (Estrogen)FDA Link 05/2017 - 04/2003
7	MicroRNAs (MicroRNA)IBA 05/2016 - 01/2011
7	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2008 - 03/2003
6	LigandsIBA 01/2022 - 11/2004
6	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 04/2003
6	Peptides (Polypeptides)IBA 01/2021 - 11/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 02/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 11/2004
5	AntioxidantsIBA 06/2022 - 03/2004
5	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 03/2004
5	RNA (Ribonucleic Acid)IBA 03/2022 - 08/2003
5	Interleukin-6 (Interleukin 6)IBA 09/2021 - 03/2004
5	Estrogen ReceptorsIBA 01/2021 - 07/2004
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 02/2013
5	Keratins (Keratin)IBA 11/2019 - 06/2003
5	EnzymesIBA 01/2017 - 03/2004
5	Phosphotransferases (Kinase)IBA 01/2017 - 05/2004
5	Cisplatin (Platino)FDA LinkGeneric 07/2016 - 10/2005
5	NF-kappa B (NF-kB)IBA 01/2016 - 03/2004
5	Transcription Factors (Transcription Factor)IBA 08/2015 - 04/2006
5	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 09/2008
5	ErbB Receptors (EGF Receptor)IBA 11/2012 - 12/2006
5	Hormones (Hormone)IBA 01/2011 - 01/2007
4	ChemokinesIBA 01/2021 - 10/2006
4	Phenobarbital (Luminal)FDA Link 01/2021 - 07/2006
4	Interleukin-8 (Interleukin 8)IBA 01/2021 - 03/2004
4	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 12/2008
4	AntigensIBA 01/2020 - 11/2005
4	CalciumIBA 06/2017 - 12/2005
4	Cyclin-Dependent Kinase Inhibitor p16IBA 03/2017 - 10/2006
4	LipidsIBA 01/2017 - 07/2008
4	ras ProteinsIBA 02/2009 - 08/2003
4	ParaffinIBA 01/2008 - 06/2003
4	AntibodiesIBA 01/2007 - 03/2004
4	Cyclin D1IBA 01/2006 - 10/2002
3	Capsules (Microcapsules)IBA 06/2022 - 07/2006
3	TitaniumIBA 04/2022 - 01/2014
3	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 05/2004
3	ProlactinIBA 01/2020 - 06/2009
3	lysophosphatidic acidIBA 01/2019 - 08/2004
3	Inhibins (Inhibin)IBA 08/2017 - 06/2003
3	Mitogen-Activated Protein KinasesIBA 01/2016 - 06/2009
3	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2013 - 12/2005
3	Indicators and Reagents (Reagents)IBA 06/2013 - 05/2006
3	Tumor Suppressor Protein p14ARF (p14ARF)IBA 06/2012 - 10/2006
3	Aurora Kinase AIBA 02/2012 - 06/2010
3	Progesterone FDA LinkGeneric 01/2011 - 03/2005
3	AndrogensIBA 01/2011 - 03/2005
3	beta CateninIBA 01/2010 - 10/2005
3	Vasopressins (Vasopressin)IBA 02/2006 - 05/2004
2	Volatile Fatty AcidsIBA 06/2022 - 01/2021
2	AcidsIBA 06/2022 - 01/2022
2	Monoamine Oxidase (MAO)IBA 04/2022 - 01/2014

Therapy/Procedure

48	Therapeutics 07/2022 - 04/2003
24	Drug Therapy (Chemotherapy) 03/2022 - 04/2003
5	Neoadjuvant Therapy 03/2022 - 01/2015
4	Radiotherapy 01/2021 - 10/2005
3	Laparotomy 10/2018 - 08/2002
3	Immunotherapy 01/2017 - 01/2007